The association of phosphatase and tensin homolog deleted on chromosome 10 polymorphisms and lifestyle habits with colorectal cancer risk in a Chinese population

Tumor Biology

Volumn 35, Issue 9, 2014, Pages 9233-9240

  Jing, Fangyuan ^a   Mao, Yingying ^a   Zhang, Zhenyu ^a   Li, Yingjun ^a   Cai, Shaofang ^a   Li, Qilong ^b   Ma, Xinyuan ^b   Jin, Mingjuan ^a   Chen, Kun ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b Institute for Cancer Prevention of Jiashan County   (China)

Author keywords

Colorectal cancer; PTEN; Single nucleotide polymorphism; Susceptibility

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PTEN PROTEIN, HUMAN; TEA;

ADULT; ARTICLE; CANCER RISK; CHINESE; CHROMOSOME DELETION; CHROMOSOME MUTATION; COLORECTAL CANCER; CONTROLLED STUDY; DRINKING; FEMALE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; LIFESTYLE HABIT; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; SEDENTARY LIFESTYLE; SINGLE NUCLEOTIDE POLYMORPHISM; TEA; AGED; ALLELE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; CHINA; COLORECTAL TUMOR; DRINKING BEHAVIOR; ETHNOLOGY; FEEDING BEHAVIOR; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HAPLOTYPE; MIDDLE AGED; NUCLEOTIDE SEQUENCE; RISK; RISK FACTOR; SMOKING;

AGED; ALCOHOL DRINKING; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; CASE-CONTROL STUDIES; CHINA; COLORECTAL NEOPLASMS; FEMALE; FOOD HABITS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PTEN PHOSPHOHYDROLASE; RISK FACTORS; SMOKING; TEA;

EID: 84919866747     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13277-014-2197-1     Document Type: Article

References (40)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11–30.
2. Dai Z, Zheng RS, Zou XN, Zhang SW, Zeng HM, Li N, et al. [Analysis and prediction of colorectal cancer incidence trend in China]. Zhonghua Yu Fang Yi Xue Za Zhi. 2012;46(7):598–603.
3. Zhang S, Cui Y, Weng Z, Gong X, Chen M, Zhong B. Changes on the disease pattern of primary colorectal cancers in Southern China: a retrospective study of 20 years. Int J Colorectal Dis. 2009;24(8):943–9.
4. Phipps AI, Baron J, Newcomb PA. Prediagnostic smoking history, alcohol consumption, and colorectal cancer survival: the Seattle Colon Cancer Family Registry. Cancer. 2011;117(21):4948–57.
5. Leufkens AM, Van Duijnhoven FJ, Siersema PD, Boshuizen HC, Vrieling A, Agudo A, et al. Cigarette smoking and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition study. Clin Gastroenterol Hepatol. 2011;9(2):137–44.
6. Wang ZH, Gao QY, Fang JY. Green tea and incidence of colorectal cancer: evidence from prospective cohort studies. Nutr Cancer. 2012;64(8):1143–52.
7. Wang XJ, Zeng XT, Duan XL, Zeng HC, Shen R, Zhou P. Association between green tea and colorectal cancer risk: a meta-analysis of 13 case-control studies. Asian Pac J Cancer Prev. 2012;13(7):3123–7.
8. Zhang Y, Liu B, Jin M, Ni Q, Liang X, Ma X, et al. Genetic polymorphisms of transforming growth factor-beta1 and its receptors and colorectal cancer susceptibility: a population-based case-control study in China. Cancer Lett. 2009;275(1):102–8.
9. Luca AC, Mersch S, Deenen R, Schmidt S, Messner I, Schafer KL, et al. Impact of the 3D microenvironment on phenotype, gene expression, and EGFR inhibition of colorectal cancer cell lines. PLoS One. 2013;8(3):e59689.
10. Valtorta E, Misale S, Sartore-Bianchi A, Nagtegaal ID, Paraf F, Lauricella C, Dimartino V, Hobor S, Jacobs B, Ercolani C et al: KRAS gene amplification in colorectal cancer and impact on response to EGFR-targeted therapy. Int J Cancer 2013.
11. Zhou C, Tong Y, Wawrowsky K, Melmed S: PTTG acts as a STAT3 target gene for colorectal cancer cell growth and motility. Oncogene 2013.
12. Yin Y, Shen WH. PTEN: a new guardian of the genome. Oncogene. 2008;27(41):5443–53.
13. Wang X, Jiang X. PTEN: a default gate-keeping tumor suppressor with a versatile tail. Cell Res. 2008;18(8):807–16.
14. Bedolla R, Prihoda TJ, Kreisberg JI, Malik SN, Krishnegowda NK, Troyer DA, et al. Determining risk of biochemical recurrence in prostate cancer by immunohistochemical detection of PTEN expression and Akt activation. Clin Cancer Res. 2007;13(13):3860–7.
15. Westekemper H, Karimi S, Susskind D, Anastassiou G, Freistuhler M, Steuhl KP, et al. Expression of HSP 90, PTEN and Bcl-2 in conjunctival melanoma. Br J Ophthalmol. 2011;95(6):853–8.
16. Khaleghpour K, Li Y, Banville D, Yu Z, Shen SH. Involvement of the PI 3-kinase signaling pathway in progression of colon adenocarcinoma. Carcinogenesis. 2004;25(2):241–8.
17. Mao C, Zhou J, Yang Z, Huang Y, Wu X, Shen H, et al. KRAS, BRAF and PIK3CA mutations and the loss of PTEN expression in Chinese patients with colorectal cancer. PLoS One. 2012;7(5):e36653.
18. Guanti G, Resta N, Simone C, Cariola F, Demma I, Fiorente P, et al. Involvement of PTEN mutations in the genetic pathways of colorectal cancerogenesis. Hum Mol Genet. 2000;9(2):283–7.
19. Carroll BT, Couch FJ, Rebbeck TR, Weber BL. Polymorphisms in PTEN in breast cancer families. J Med Genet. 1999;36(2):94–6.
20. Chen M, Cassidy A, Gu J, Delclos GL, Zhen F, Yang H, et al. Genetic variations in PI3K-AKT-mTOR pathway and bladder cancer risk. Carcinogenesis. 2009;30(12):2047–52.
21. Chen J, Shao P, Cao Q, Li P, Li J, Cai H, et al. Genetic variations in a PTEN/AKT/mTOR axis and prostate cancer risk in a Chinese population. PLoS One. 2012;7(7):e40817.
22. Starinsky S, Figer A, Ben-Asher E, Geva R, Flex D, Fidder HH, et al. Genotype phenotype correlations in Israeli colorectal cancer patients. Int J Cancer. 2005;114(1):58–73.
23. Kim JG, Chae YS, Sohn SK, Kang BW, Moon JH, Lee SJ, et al. Clinical significance of genetic variations in the PI3K/PTEN/AKT/mTOR pathway in Korean patients with colorectal cancer. Oncology. 2010;79(3–4):278–82.
24. Slattery ML, Herrick JS, Lundgreen A, Fitzpatrick FA, Curtin K, Wolff RK. Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1. Carcinogenesis. 2010;31(9):1604–11.
25. Phillips LS, Thompson CL, Merkulova A, Plummer SJ, Tucker TC, Casey G, et al. No association between phosphatase and tensin homolog genetic polymorphisms and colon cancer. World J Gastroenterol. 2009;15(30):3771–5.
26. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21(2):263–5.
27. Andersson T, Alfredsson L, Kallberg H, Zdravkovic S, Ahlbom A. Calculating measures of biological interaction. Eur J Epidemiol. 2005;20(7):575–9.
28. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res. 2001;125(1–2):279–84.
29. Jan CH, Friedman RC, Ruby JG, Bartel DP. Formation, regulation and evolution of Caenorhabditis elegans 3′UTRs. Nature. 2011;469(7328):97–101.
30. Fang Z, Rajewsky N. The impact of miRNA target sites in coding sequences and in 3′UTRs. PLoS One. 2011;6(3):e18067.
31. Bruno AE, Li L, Kalabus JL, Pan Y, Yu A, Hu Z. miRdSNP: a database of disease-associated SNPs and microRNA target sites on 3′UTRs of human genes. BMC Genomics. 2012;13:44.
32. Wu Y, Jin M, Liu B, Liang X, Yu Y, Li Q, et al. The association of XPC polymorphisms and tea drinking with colorectal cancer risk in a Chinese population. Mol Carcinog. 2011;50(3):189–98.
33. Xu WH, Dai Q, Xiang YB, Long JR, Ruan ZX, Cheng JR, et al. Interaction of soy food and tea consumption with CYP19A1 genetic polymorphisms in the development of endometrial cancer. Am J Epidemiol. 2007;166(12):1420–30.
34. Ding J, Gao Y, Liu R, Xu F, Liu H. Association of PTEN polymorphisms with susceptibility to hepatocellular carcinoma in a Han Chinese population. DNA Cell Biol. 2011;30(4):229–34.
35. Rearick D, Prakash A, McSweeny A, Shepard SS, Fedorova L, Fedorov A. Critical association of ncRNA with introns. Nucleic Acids Res. 2011;39(6):2357–66.
36. Roy SW, Gilbert W. The evolution of spliceosomal introns: patterns, puzzles and progress. Nat Rev Genet. 2006;7(3):211–21.
37. Hakim IA, Chow HH, Harris RB. Green tea consumption is associated with decreased DNA damage among GSTM1-positive smokers regardless of their hOGG1 genotype. J Nutr. 2008;138(8):1567S–71S.
38. Kawai Y, Matsui Y, Kondo H, Morinaga H, Uchida K, Miyoshi N, et al. Galloylated catechins as potent inhibitors of hypochlorous acid-induced DNA damage. Chem Res Toxicol. 2008;21(7):1407–14.
39. Kuzuhara T, Tanabe A, Sei Y, Yamaguchi K, Suganuma M, Fujiki H. Synergistic effects of multiple treatments, and both DNA and RNA direct bindings on, green tea catechins. Mol Carcinog. 2007;46(8):640–5.
40. Xu YY, Jin HY, Tan XZ, Liu XF, Ding YJ. [Tea polyphenol inhibits colorectal cancer with microsatellite instability by regulating the expressions of HES1, JAG1, MT2A and MAFA]. Zhong Xi Yi Jie He Xue Bao. 2010;8(9):870–6.